CoviDx™ SARS-CoV-2 Rapid Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal (NS) swabs and nasopharyngeal (NP) swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first 5 days of symptoms.

  • Results in 15 minutes. 
  • CoviDx allows for optimal disease management and immediate patient isolation 
  • Pre-filled extraction vials and individually wrapped swabs enable multiple independent workstations for increased test distribution 
  • Facilitates professionally administered testing at the point of need, such as workplace testing and airport screening 
  • Room temperature storage 
  • 25 test kit

The COVIDx-SARS-CoV-2 Rapid Antigen Test Kit is manufactured in the United States by Lumos Diagnostics Inc. and was approved by Health Canada on November 2, 2021.

Buy the COVIDx-SARS-CoV-2 Rapid Antigen Test Kit for Your WorkPlace

If your company or organization is interested in rapid testing solutions, contact us today for help procuring the COVIDx-SARS-CoV-2 Rapid Antigen Test Kit or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Proudly trusted by hundreds of organizations across Canada

Stay up to date with Rapid Test & Trace Canada

Scroll to Top
Tweet
Share
Share
WhatsApp
Pin